A study aimed at determining the efficacy and safety of the antiparisitic drug ivermectin on COVID-19 patients has been terminated, Science and Technology Secretary Fortunato de la Peña said on Friday. In April 2021, the two agencies expressed their support in conducting the local clinical study on ivermectin to provide data on its safety and efficacy in treating COVID. “[The clinical trial] has been stopped. In a clinical trial published in March, the New England Journal of Medicine supported the warning of medical experts against the use of ivermectin for COVID-19 treatmentThe latest clinical trial published on March 30 in The New England Journal of Medicine backed warnings by medical experts against the use of ivermectin for the prevention and treatment of COVID-19. The research conducted between March and August 2021 examined the efficacy of the drug among patients in various public health clinics.

Source: Philippine Daily Inquirer May 23, 2022 00:13 UTC